J. V. Nes

The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies

J. Nortier, Stephen E. Jones, A. Hasenburg, 2011, Journal of Cancer Research and Clinical Oncology.

P288 Effects of exemestane or tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis

Stephen E. Jones, A. Hasenburg, P. Hadji, 2011 .

Early Breast Cancer Patients Prognostic Value for Clinical Outcome of HLA Class I-Negative Tumors Is of HLA-E and HLA-G Expression in Classical

Gerrit, H. Putter, P. Kuppen, 2010 .

Tumor-Stroma Ratio within the Primary Tumor Is a Prognostic Factor in Early Breast Cancer Patients, Especially in Triple-Negative-Carcinoma Patients.

H. Putter, R. Tollenaar, P. Kuppen, 2009 .

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

Hein Putter, Peter J. K. Kuppen, Rob A. E. M. Tollenaar, 2011, Breast Cancer Research and Treatment.

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study

H. Putter, A. Giuliano, D. Elashoff, 2012, Breast Cancer Research and Treatment.

Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer

H. Putter, A. Giuliano, P. Kuppen, 2012, Breast Cancer Research and Treatment.

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients

H. Putter, P. Kuppen, J. Bartlett, 2011, Breast Cancer Research and Treatment.

COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients

H. Putter, M. Vijver, P. Kuppen, 2011, Breast Cancer Research and Treatment.

Paragangliomas of the Head and Neck

H. Urk, M. V. Sambeek, S. D. Jong, 2006 .

Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients

H. Putter, P. Kuppen, S. Noguchi, 2009, British Journal of Cancer.

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer.

C. V. D. van de Velde, S. Verma, K. Pritchard, 2010, Cancer treatment reviews.

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.

H. Putter, C. Seynaeve, J. Nortier, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.

H. Putter, H. Bartelink, L. Collette, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.